Taiwan · Delayed Price · Currency is TWD BIONET Statistics
Total Valuation
BIONET has a market cap or net worth of TWD 5.21 billion. The enterprise value is 4.79 billion.
| Market Cap | 5.21B |
| Enterprise Value | 4.79B |
Important Dates
The next estimated earnings date is Tuesday, March 17, 2026.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
BIONET has 50.31 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 50.31M |
| Shares Outstanding | 50.31M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 7.86% |
| Owned by Institutions (%) | 1.69% |
| Float | 39.73M |
Valuation Ratios
The trailing PE ratio is 74.96.
| PE Ratio | 74.96 |
| Forward PE | n/a |
| PS Ratio | 4.26 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | 72.84 |
| P/OCF Ratio | 29.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 91.97, with an EV/FCF ratio of 66.98.
| EV / Earnings | 68.58 |
| EV / Sales | 3.92 |
| EV / EBITDA | 91.97 |
| EV / EBIT | n/a |
| EV / FCF | 66.98 |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.20 |
| Quick Ratio | 3.85 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 0.83 |
| Interest Coverage | 2.12 |
Financial Efficiency
Return on equity (ROE) is 0.53% and return on invested capital (ROIC) is 0.08%.
| Return on Equity (ROE) | 0.53% |
| Return on Assets (ROA) | 0.06% |
| Return on Invested Capital (ROIC) | 0.08% |
| Return on Capital Employed (ROCE) | 0.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.41 |
| Inventory Turnover | 5.21 |
Taxes
In the past 12 months, BIONET has paid 28.71 million in taxes.
| Income Tax | 28.71M |
| Effective Tax Rate | 71.14% |
Stock Price Statistics
The stock price has increased by +30.19% in the last 52 weeks. The beta is 0.53, so BIONET's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +30.19% |
| 50-Day Moving Average | 99.10 |
| 200-Day Moving Average | 80.94 |
| Relative Strength Index (RSI) | 51.78 |
| Average Volume (20 Days) | 776,417 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIONET had revenue of TWD 1.22 billion and earned 69.82 million in profits. Earnings per share was 1.38.
| Revenue | 1.22B |
| Gross Profit | 680.81M |
| Operating Income | 2.93M |
| Pretax Income | 40.35M |
| Net Income | 69.82M |
| EBITDA | 39.15M |
| EBIT | 2.93M |
| Earnings Per Share (EPS) | 1.38 |
Balance Sheet
The company has 1.46 billion in cash and 59.44 million in debt, giving a net cash position of 1.41 billion or 27.93 per share.
| Cash & Cash Equivalents | 1.46B |
| Total Debt | 59.44M |
| Net Cash | 1.41B |
| Net Cash Per Share | 27.93 |
| Equity (Book Value) | 2.24B |
| Book Value Per Share | 24.98 |
| Working Capital | 1.45B |
Cash Flow
In the last 12 months, operating cash flow was 179.20 million and capital expenditures -107.72 million, giving a free cash flow of 71.48 million.
| Operating Cash Flow | 179.20M |
| Capital Expenditures | -107.72M |
| Free Cash Flow | 71.48M |
| FCF Per Share | 1.42 |
Margins
Gross margin is 55.71%, with operating and profit margins of 0.24% and 5.71%.
| Gross Margin | 55.71% |
| Operating Margin | 0.24% |
| Pretax Margin | 3.30% |
| Profit Margin | 5.71% |
| EBITDA Margin | 3.20% |
| EBIT Margin | 0.24% |
| FCF Margin | 5.85% |
Dividends & Yields
This stock pays an annual dividend of 1.42, which amounts to a dividend yield of 1.37%.
| Dividend Per Share | 1.42 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | 99.69% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 47.49% |
| Buyback Yield | -0.15% |
| Shareholder Yield | 1.22% |
| Earnings Yield | 1.34% |
| FCF Yield | 1.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 19, 2024. It was a forward split with a ratio of 1.070923771.
| Last Split Date | Sep 19, 2024 |
| Split Type | Forward |
| Split Ratio | 1.070923771 |
Scores
BIONET has an Altman Z-Score of 3.87 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 5 |